Status:
WITHDRAWN
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects
Lead Sponsor:
University of North Texas Health Science Center
Conditions:
Healthy
Eligibility:
All Genders
18+ years
Brief Summary
RLIP76 (Ral binding protein1) is a 76 kDa splice variant protein encoded by the human gene (RALBP1, 18p11.22). It is a multifunctional modular protein found ubiquitously from Drosophila to humans, in ...
Detailed Description
RLIP76 is shown to be over expressed in a variety of cancer cells. However, no study has yet been done on its expression on normal cells. The studies proposed in this project will study the expression...
Eligibility Criteria
Inclusion
- Healthy as defined by lack of serious health conditions or diseases
Exclusion
- Children, pregnant women, prisoners, persons with any medical condition that precludes phlebotomy and persons unwilling or unable to provide consent will be excluded.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00762801
Start Date
September 1 2008
End Date
September 1 2011
Last Update
October 26 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Texas Health Science Center
Fort Worth, Texas, United States, 76107
2
University of North Texas Health Science Center
Fort Worth, Texas, United States, 76109